Anemia of Chronic Disease
Top Cited Papers
- 10 March 2005
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (10), 1011-1023
- https://doi.org/10.1056/nejmra041809
Abstract
New therapeutic strategies have emerged along with our understanding that disturbances of iron homeostasis, impaired proliferation of erythroid progenitor cells, and blunted erythropoietin response occur in anemia of chronic disease. This review discusses advances in our knowledge of the causes and management of the condition.Keywords
This publication has 91 references indexed in Scilit:
- Pure Red-Cell Aplasia and Epoetin TherapyNew England Journal of Medicine, 2004
- Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy WomenJAMA, 2004
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- Increased Expression of Erythropoiesis Inhibiting Cytokines (IFN-γ, TNF-α, IL-10, and IL-13) by T Cells in Patients Exhibiting a Poor Response to Erythropoietin TherapyJournal of the American Society of Nephrology, 2003
- Erythropoietin stimulates proliferation of human renal carcinoma cellsKidney International, 2000
- Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritisRheumatology International, 1996
- Inadequate erythropoietin response to anemia: definition and clinical relevanceAnnals of Hematology, 1994
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Decreased Erythropoietin Response in Patients with the Anemia of CancerNew England Journal of Medicine, 1990
- Body Iron Stores and the Risk of CancerNew England Journal of Medicine, 1988